Pyoderma gangrenosum caused by secukinumab successfully treated with risankizumab: a case report and literature review. Orita A, Hoshina D, Hirosaki K. Clin Exp Dermatol 2022;47:1372-1374.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Orita A, Hoshina D, Hirosaki K. Pyoderma gangrenosum caused by secukinumab successfully treated with risankizumab: a case report and literature review. Clin Exp Dermatol 2022;47:1372-1374.
PMID: 35298047